Plasfer is trasforming blood platelets into cellular medicines
Isolation of platelets
A medical device is utilized for the loading of the platelets.
Platelet concentrates, obtained from whole blood, are automatically loaded with drugs/compounds.
Loaded platelets
Platelet-mediated delivery of oligonucleotides, small molecule, and antibodies/proteins
In vivo target
Platelet concentrates as drug carriers for the therapeutic targeting of solid
cancer and of inflammatory diseases (Rheumatoid arthritis).
Our Technology
Our technology exploits the unique properties of platelets which have been shown to be able to deliver nucleic acids, proteins and small molecules to various cell types, as cancer cells, pathogen agents, and subendothelial layer. Plasfer will enhance the capability of platelets to deliver payloads to specific cell and tissue types.
Patented Technology
The power of Platelets
Easy to separate, easy to load with payloads, easy targeting in vivo
Strong Intellectual Property
A portfolio of IP for using exclusively platelets as drug delivery tool
High qualified team
An high qualified and differentiated team with a strong and acknowledged scientific background
High Innovation
A technology with highly innovative impact in cell therapy
Plasfer Team
GROWING MARKET
Plasfer is in preclinical stage. Plasfer will lead the power of platelets to deliver nucleic acids to treat a diverse array of cancer and non-cancer indications.
Last News
-
Participation at BIO-Europe 19
in NewsFrom 11th to 13th of November Plasfer, represented by the CEO Dr. Marco Malvestiti and Att...
-
Participation at 19th Annual Biotech in Europe FORUM
in NewsPlasfer took part in the “19TH ANNUAL BIOTECH IN EUROPE FORUM” in Basel from S...
-
Communication to shareholders – Comunicazione ai soci circa l’aumento di capitale
in NewsPerugia, 17/01/19 Si invitano i soci a prendere visione della documentazione scaricabile d...
-
Call for a PhD student
in NewsPerugia, Italy – August 14, 2018. Plasfer has closed an agreement with the Univer...
Award e Partner
